Chronic Lymphocytic Leukemia

>

The OncLive Chronic Lymphocytic Leukemia condition center page is a comprehensive resource for clinical news and expert insights on treatment advances and ongoing research in chronic lymphocytic leukemia. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs and updates with chronic lymphocytic leukemia therapy.

Latest News

R/R CLL | Image credit:  © LELISAT - stock.adobe.com
Long-Term Data Support Venetoclax Plus Rituximab in Relapsed/Refractory CLL

June 18th 2025

Venetoclax plus rituximab displayed OS and PFS benefits vs BR after long-term follow-up in relapsed/refractory CLL.

Mazyar Shadman, MD, MPH, of Fred Hutch Cancer Center
Zanubrutinib/Venetoclax Yields Deep Responses in Treatment-Naive CLL Regardless of Del17p/TP53 Mutational Status

June 18th 2025

Paolo Ghia, MD, PhD
Hematologists Highlight Notable Insights From the 2025 EHA Congress

June 18th 2025

CLL/SLL | Image Credit: © Oleksandr - stock.adobe.com
Pirtobrutinib Improves Patient-Reported Outcomes in Relapsed/Refractory CLL/SLL

June 16th 2025

Image Credit: © Bipul Kumar - stock.adobe.com
MAIC Analysis Shows PFS Favorability With Zanubrutinib vs Acalabrutinib/Venetoclax in CLL

June 16th 2025

Video Series
Video Interviews
Podcasts
OncLive On Air
Talal Hilal, MD, MB, BCh

More News